152 related articles for article (PubMed ID: 2309678)
1. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
2. Results of a television-advertised public screening program for colorectal cancer.
McGarrity TJ; Long PA; Peiffer LP; Converse JO; Kreig AF
Arch Intern Med; 1989 Jan; 149(1):140-4. PubMed ID: 2912403
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
4. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
7. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
8. Detecting colorectal cancer with a large scale fecal occult blood testing program.
Gregorio DI; Lolachi P; Hansen H
Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
10. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
[TBL] [Abstract][Full Text] [Related]
11. Mass screening for colorectal cancer in Japan.
Hisamichi S; Fukao A; Fujii Y; Tsuji I; Komatsu S; Inawashiro H; Tsubono Y
Cancer Detect Prev; 1991; 15(5):351-6. PubMed ID: 1751945
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
[TBL] [Abstract][Full Text] [Related]
13. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
[TBL] [Abstract][Full Text] [Related]
14. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
15. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
Mahon SM
Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
[TBL] [Abstract][Full Text] [Related]
16. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
19. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
20. Fecal occult blood testing for colorectal cancer in an ethnically diverse population.
Glober GA; Hundahl S; Stucke J; Choy M
West J Med; 1994 Oct; 161(4):377-82. PubMed ID: 7817548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
